Firms
Theme

G

GENPACT LIMITED · NYSE

News

7 latest

Zacks Investment Research

Will Genpact (G) Beat Estimates Again in Its Next Earnings Report?

Genpact (G), a business process management services provider, shows strong potential for another earnings beat in its upcoming November 5, 2026 report. The company has a track record of beating earnings estimates with an average surprise of 4.23% over the last two quarters and currently has a positive Earnings ESP of +1.34% combined with a Zacks Rank #3 (Hold), suggesting a high probability of outperforming consensus estimates.

Zacks Investment Research

G vs. NTNX: Which Stock Should Value Investors Buy Now?

Genpact (G) and Nutanix (NTNX) are both Computers - IT Services stocks with a Zacks Rank #2 (Buy), but Genpact emerges as the superior value option. Genpact has a forward P/E of 8.36 and a Value grade of A, while Nutanix has a forward P/E of 32.32 and a Value grade of F, making Genpact significantly more undervalued based on traditional valuation metrics.

Zacks Investment Research

Here's Why Genpact (G) is a Strong Value Stock

Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) that work alongside the Zacks Rank system to help investors identify high-probability stocks. The Zacks Rank #1 stocks have averaged +23.86% annual returns since 1988, more than double the S&P 500. Genpact (G) is highlighted as a #2 Buy with strong Value and VGM scores.

Zacks Investment Research

Reasons Why Investors Can Consider Buying Genpact Stock Now

Genpact Limited (G) has outperformed its industry with 13.6% share gains over three months. The company is positioned for sustained growth driven by its Agentic Solutions strategy, with 2026 revenues and earnings projected to grow 7% and 12.6% year-over-year respectively. Agentic Solutions is on track to exceed $1B in contract value in 2026, supported by strong liquidity and consistent shareholder returns through buybacks and dividend increases.

Mentions G

Zacks Investment Research

Innodata Stock's Premium Valuation: Can AI Growth Justify the Price?

Innodata (INOD) trades at a premium 35.47X forward P/E ratio despite a 34.3% stock decline over the past year. While the company benefits from strong AI demand with Q2 revenues surging 58% to $92.1 million and adjusted EBITDA jumping 92%, concerns about customer concentration (top two customers represent 71% of revenues), margin volatility, and downward 2027 earnings revisions warrant caution. The stock receives a Zacks Rank #3 (Hold) rating, suggesting investors await better entry points.

Zacks Investment Research

TD SYNNEX Surges 78% YTD: Is the SNX Stock Still Worth Buying?

TD SYNNEX (SNX) has surged 78% year-to-date, significantly outperforming its IT Services industry peers. Strong Q3 fiscal 2026 results showed 37.7% revenue growth and 58.7% non-GAAP EPS growth, driven by robust AI infrastructure demand. With a forward P/E of 11.26X below the industry average of 17.98X, the stock is rated a Zacks Rank #1 Strong Buy, offering continued upside potential for investors seeking AI and technology exposure.

Zacks Investment Research

INOD vs. EXLS: Which AI & Data Services Stock Has More Upside?

Innodata (INOD) and ExlService (EXLS) are both benefiting from rising AI adoption, but with different profiles. INOD shows faster growth with 56.1% first-half revenue surge and trades at a premium valuation (43.31X forward P/E), while EXLS offers greater scale, diversification, and profitability at a cheaper valuation (13.71X forward P/E). For growth-focused investors, INOD has more upside potential despite higher risks; EXLS presents a more balanced, defensive option.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $G · 0 threads

Sign in to post on $G

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev